US6036931029 - Common Stock
MINK THERAPEUTICS INC
NASDAQ:INKT (5/17/2024, 7:06:14 PM)
After market: 1.01 0 (0%)1.01
-0.03 (-2.88%)
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company is headquartered in New York City, New York and currently employs 37 full-time employees. The company went IPO on 2021-10-15. The company is focused on the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells are a distinct T cell population that combine durable memory responses with the rapid cytolytic features of natural killer cells. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells and suppress Graft versus Host Disease. Its platform is designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. Its engineered programs are MiNK-413, an IL-15 armored CAR-iNKT program targeting B cell maturation antigen, and MiNK-215, an IL-15 armored tumor stromal targeting FAP-CAR-iNKT program.
MINK THERAPEUTICS INC
149 Fifth Avenue, Suite 500
New York City NEW YORK
P: 12129948250
Employees: 37
Website: https://www.minktherapeutics.com
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
INKT stock results show that MiNK Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Completed $5.8 million private placement financing at 25% premium Upcoming presentation of agenT-797 in severe respiratory distress at the American...
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Here you can normally see the latest stock twits on INKT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: